Literature DB >> 30021823

Bronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 Episodes.

A Fernández-Cruz1,2, E Magira3,4, S T Heo3,5, S Evans6, J Tarrand7, D P Kontoyiannis1.   

Abstract

There is a paucity of studies on the yield of Gomori-methenamine-silver (GMS) staining in bronchoalveolar lavage (BAL) fluid cytology and its comparison with fluorescent dye staining for the diagnosis of invasive pulmonary aspergillosis (IPA) in patients with hematologic malignancies. To that end, we analyzed the yield of direct fungal visualization in BAL fluid cytology with GMS staining, in a series of culture-positive IPA cases in 67 patients with hematologic malignancies, and we compared the results with those of direct examination with calcofluor white staining and BAL fluid galactomannan assays, when available. GMS staining in BAL fluid cytology was positive in 42% of the 67 cases and revealed coinfections in 7 cases. In contrast, only 2/67 (3.6%) BAL fluid samples were positive in direct smears stained with the fluorescent dye calcofluor white. Positive GMS staining results were significantly more frequent in IPA cases with cavitary lesions and IPA cases caused by >1 Aspergillus species, but the proportions of positive cytology results among Aspergillus species were not different.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  GMS; hematologic malignancy; invasive aspergillosis

Mesh:

Substances:

Year:  2018        PMID: 30021823      PMCID: PMC6156316          DOI: 10.1128/JCM.00962-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Expert review of histologic slides and Papanicolaou tests in the context of litigation or potential litigation. Surgical Pathology Committee and Cytopathology Committee of the College of American Pathologists.

Authors:  P L Fitzgibbons; R M Austin
Journal:  Arch Pathol Lab Med       Date:  2000-11       Impact factor: 5.534

2.  The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis.

Authors:  H Levy; D A Horak; B R Tegtmeier; S B Yokota; S J Forman
Journal:  Respir Med       Date:  1992-05       Impact factor: 3.415

3.  The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis.

Authors:  F W Kahn; J M Jones; D M England
Journal:  Am J Clin Pathol       Date:  1986-10       Impact factor: 2.493

4.  Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia.

Authors:  H Saito; E J Anaissie; R C Morice; R Dekmezian; G P Bodey
Journal:  Chest       Date:  1988-10       Impact factor: 9.410

5.  Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia.

Authors:  S M Albelda; G H Talbot; S L Gerson; W T Miller; P A Cassileth
Journal:  Am J Med       Date:  1984-06       Impact factor: 4.965

6.  Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.

Authors:  Johan A Maertens; Issam I Raad; Kieren A Marr; Thomas F Patterson; Dimitrios P Kontoyiannis; Oliver A Cornely; Eric J Bow; Galia Rahav; Dionysios Neofytos; Mickael Aoun; John W Baddley; Michael Giladi; Werner J Heinz; Raoul Herbrecht; William Hope; Meinolf Karthaus; Dong-Gun Lee; Olivier Lortholary; Vicki A Morrison; Ilana Oren; Dominik Selleslag; Shmuel Shoham; George R Thompson; Misun Lee; Rochelle M Maher; Anne-Hortense Schmitt-Hoffmann; Bernhardt Zeiher; Andrew J Ullmann
Journal:  Lancet       Date:  2015-12-10       Impact factor: 79.321

7.  Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: a prospective 2-year study.

Authors:  Fotis Sampsonas; Dimitrios P Kontoyiannis; Burton F Dickey; Scott E Evans
Journal:  Cancer       Date:  2011-01-18       Impact factor: 6.860

8.  Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Authors:  A J Ullmann; J M Aguado; S Arikan-Akdagli; D W Denning; A H Groll; K Lagrou; C Lass-Flörl; R E Lewis; P Munoz; P E Verweij; A Warris; F Ader; M Akova; M C Arendrup; R A Barnes; C Beigelman-Aubry; S Blot; E Bouza; R J M Brüggemann; D Buchheidt; J Cadranel; E Castagnola; A Chakrabarti; M Cuenca-Estrella; G Dimopoulos; J Fortun; J-P Gangneux; J Garbino; W J Heinz; R Herbrecht; C P Heussel; C C Kibbler; N Klimko; B J Kullberg; C Lange; T Lehrnbecher; J Löffler; O Lortholary; J Maertens; O Marchetti; J F Meis; L Pagano; P Ribaud; M Richardson; E Roilides; M Ruhnke; M Sanguinetti; D C Sheppard; J Sinkó; A Skiada; M J G T Vehreschild; C Viscoli; O A Cornely
Journal:  Clin Microbiol Infect       Date:  2018-03-12       Impact factor: 8.067

9.  Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study.

Authors:  Russell E Lewis; Lizebeth Cahyame-Zuniga; Konstantinos Leventakos; Georgios Chamilos; Ronen Ben-Ami; Pheroze Tamboli; Jeffrey Tarrand; Gerald P Bodey; Mario Luna; Dimitrios P Kontoyiannis
Journal:  Mycoses       Date:  2013-04-04       Impact factor: 4.377

10.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

View more
  2 in total

1.  American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients.

Authors:  Sanjeet S Dadwal; Tobias M Hohl; Cynthia E Fisher; Michael Boeckh; Genofeva Papanicolaou; Paul A Carpenter; Brian T Fisher; Monica A Slavin; D P Kontoyiannis
Journal:  Transplant Cell Ther       Date:  2021-03

2.  The grim reaper evading modern medicine: aspergillosis, adenovirus, and Hodgkin lymphoma.

Authors:  Larry Nichols; Justin Armstrong; Cody Atkinson
Journal:  Autops Case Rep       Date:  2020-09-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.